ESR1 and breast cancer: Consistently, the E2-triggering of ER has been found to restrain the expression of PDL1 proteins in MCF-7 but not in MDA-MB-231 BC cells, an effect that can be reversed by culturing the former in a steroid-free medium or fulvestrant treatment [30,57,58].